|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
ÀÎÇã°¡»ç¾÷ºÎ ÀÇ·á±â±â»ç¾÷ÆÀ ½ÅÀÔ/°æ·Â ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
»ó½Ãä¿ë |
01.03 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
(Sr.)CRA ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
07.24 |
|
|
ÁöÀÌÇコÄɾîÄÚ¸®¾Æ |
[GE Healthcare] Lead Finance Analyst - FP&A »ç¿ø´ë¸®±Þ
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
1³â¡è |
ä¿ë½Ã |
01.31 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
MSD Clinical research associate(CRA)´Ù¼ö ¸ðÁý Áß
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
11.06 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
RA Specialist ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
06.20 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
MSDµ¿¹°¾àÇ° °ü¸®¾à»ç ¸ðÁý(½ÅÀÔ °¡´É)
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.17 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
[LSK Global PS] SSUA ä¿ë
¼¿ï Áß±¸ | Çз¹«°ü |
SSU |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.18 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
(Sr.)CRA ´Ù¼ö ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
05.21 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
(Sr.)RA Specialist 2¸í ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
05.13 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
[Çѱ¹MSD]Business practice officer(Compliance officer)
¼¿ï Áß±¸, ¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
2³â¡è |
ä¿ë½Ã |
05.10 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
¸ÞµðÇïÇÁ¶óÀÎ ÀÓ»ó½ÃÇè CRA °æ·Â&½ÅÀÔ Ã¤¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.30 |
|
|
(ÁÖ)À¯À¯Á¦¾à |
À¯À¯Á¦¾à Àӻ󿬱¸ÆÀ °æ·ÂÁ÷ ¸ðÁý
¼¿ï Áß±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
04.05 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
BD(Business Development) ½ÅÀÔ/°æ·ÂÁ÷ ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
06.29 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
¸ÞµðÇïÇÁ¶óÀÎ 2019³â »ó¹Ý±â ÀÓ»ó/Åë°è/µ¥ÀÌÅÍ °æ·Â&½ÅÀÔ Ã¤
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.13 |
|
|
Äû¾ÆÁ¨ÄÚ¸®¾Æ À¯ÇÑȸ»ç |
Äû¾ÆÁ¨ÄÚ¸®¾Æ Customer Care Representative
¼¿ï Áß±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.19 |
|